-56%

est. 2Y upside i

HealthcareSeries A

AI-powered virtual care for chronic lung disease

Rank

#217

Sector

Healthcare

Est. Liquidity

~5Y

Data Quality

Data: Medium

This opportunity offers significant upside potential driven by Kivo Health's specialized AI-powered virtual pulmonary rehabilitation program and growing partnerships, but comes with inherent early-stage risks related to limited funding, scaling challenges, and an active competitive landscape.

Last updated: February 15, 2026

Bull (25%)+400%

Kivo Health successfully expands its partnerships, demonstrates significant patient outcome improvements and cost savings, and secures substantial follow-on funding, leading to a high-multiple acquisition or IPO.

Base (45%)+150%

Kivo Health continues to grow steadily, expands its customer base, and secures additional funding at a healthy valuation, but faces ongoing competitive pressures and slower market penetration.

Bear (30%)-90%

Kivo Health struggles to scale, faces intense competition from better-funded incumbents or direct competitors, fails to secure sufficient follow-on funding, or encounters significant regulatory hurdles.

Est. time to liquidity~5.0 years

Community

Valuation Sentiment

Our model estimates -56% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.